UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...
EliLilly’s (LLY) Kisunla for Alzheimer’s, and Merck’s (MRK) Winrevair for pulmonary arterial hypertension. Viking Therapeutics stock ramped higher Thursday after the company outlined its ...
Some results have been hidden because they may be inaccessible to you